This delivery strategy allowed a greater release of IFN-γ in the tumor site compared to what was found in mice treated with IFN-γ not conjugated with NPs: this leads to a more efficient immune response against the tumor and a major decrease in the tumor growth.105. This evidence concerns the gene IFNG and neoplasm.